Ultragenyx Pharmaceutical | RARE - Creditori Commerciali





Creditori Commerciali Cambiamento Data
Acadia Pharmaceuticals USD 44.57M 32.32M 2026-06
Agios Pharmaceuticals USD 16.34M 2.6M 2026-06
Alnylam Pharmaceuticals USD 108.02M 18.61M 2026-06
BioCryst Pharmaceuticals USD 11.46M 501K 2026-06
BioMarin Pharmaceutical USD 913.67M 120.52M 2026-06
Immunic USD 11.01M 873K 2026-03
Insmed USD 74.55M 1.18M 2026-06
Ionis Pharmaceuticals USD 47.7M 21.67M 2026-06
Karyopharm Therapeutics USD 4.28M 276K 2026-03
Kyowa Hakko Kirin JPY 125.29B 17.7B 2026-06
MacroGenics USD 3.44M 845K 2026-06
Moderna USD 167M 6M 2026-06
Neurocrine Biosciences USD 691.3M 145.8M 2026-03
PTC Therapeutics USD 40.45M 14.96M 2026-06
Puma Biotechnology USD 6.39M 962K 2025-09
Regeneron Pharmaceuticals USD 1.16B 132.2M 2026-06
Sarepta Therapeutics USD 50.98M 19.39M 2026-06
Ultragenyx Pharmaceutical USD 39M 3M 2026-06
Vertex Pharmaceuticals USD 3.61B 135M 2026-06